KRISTEN LEE: Open Payments
NPI 1649216789 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 24 payments from 12 companies in 2025. Trend: 2023 $1,568 · 2024 $992 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 1 | $95 |
| Aimmune Therapeutics, Inc. | 1 | $88 |
| Lilly USA, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Novo Nordisk Inc | 3 | $52 |
| Corcept Therapeutics | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: t:slim X2 Insulin Pump with Control-IQ, ZENPEP, CAPLYTA, Korlym, FARXIGA, JARDIANCE, REXULTI, RECORLEV.
Industry payments across FL — which companies pay providers there.
